{
    "organizations": [],
    "uuid": "36770973153a34d1bd268ef00a887cdf328996dc",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-eleven-biotherapeutics-q1-loss-per/brief-eleven-biotherapeutics-q1-loss-per-share-0-11-idUSASC0A2EF",
    "ord_in_thread": 0,
    "title": "BRIEF-Eleven Biotherapeutics Q1 Loss Per Share $0.11",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - Eleven Biotherapeutics Inc:\n* ELEVEN BIOTHERAPEUTICS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PIPELINE UPDATES\n* Q1 LOSS PER SHARE $0.11 * THERE WAS NO REVENUE FOR QUARTER ENDED MARCH 31, 2018, COMPARED TO $0.4 MILLION FOR SAME PERIOD IN 2017\n* ELEVEN BIOTHERAPEUTICS -REVENUE FALL DUE TO REDUCTION IN REVENUE RECOGNIZED FROM COâ€™S LICENSE AGREEMENT WITH F. HOFFMANN-LA ROCHE LTD, HOFFMANN-LA ROCHE INC\n* COMPANY MAINTAINS IT WILL HAVE CAPITAL TO FUND ITS CURRENT OPERATING PLANS INTO EARLY 2019 Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-16T04:25:00.000+03:00",
    "crawled": "2018-05-16T18:46:20.015+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "eleven",
        "biotherapeutics",
        "inc",
        "eleven",
        "biotherapeutics",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "pipeline",
        "update",
        "q1",
        "loss",
        "per",
        "share",
        "revenue",
        "quarter",
        "ended",
        "march",
        "compared",
        "million",
        "period",
        "eleven",
        "biotherapeutics",
        "fall",
        "due",
        "reduction",
        "revenue",
        "recognized",
        "co",
        "license",
        "agreement",
        "roche",
        "ltd",
        "roche",
        "inc",
        "company",
        "maintains",
        "capital",
        "fund",
        "current",
        "operating",
        "plan",
        "early",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}